DEA

Full Text of 2018 HHS Letter to DEA Rescinding Kratom Ban Recommendation

DEPARTMENT OF HEALTH AND HUMAN SERVICESOffice of the SecretaryOffice of the Assistant Secretary for HealthWashington, D.C. 20201 AUG 16 2018 [stamped] The Honorable Uttam DhillonActing AdministratorDrug Enforcement AdministrationU.S. Department of Justice8701 Morrissette DriveSpringfield, VA 22152 Dear Mr. Dhillon: Pursuant to the Controlled Substances Act (CSA), 21 U.S.C. § 811, I am rescinding our prior recommendation …

Full Text of 2018 HHS Letter to DEA Rescinding Kratom Ban Recommendation Read More »

FDA Head Ranted About Kratom on Twitter a Day After HHS Quietly Withdrew Ban Recommendation

On August 16, 2018, Brett Giroir, Assistant Secretary of Health for the Department of Health and Human Services (HHS) sent a letter to then Acting Administrator of the Drug Enforcement Administration (DEA), Uttam Dhillon, rescinding a previous HHS recommendation that kratom should be federally outlawed. Pursuant to the Controlled Substances Act…, I am rescinding our …

FDA Head Ranted About Kratom on Twitter a Day After HHS Quietly Withdrew Ban Recommendation Read More »

Federal Actions on Kratom: 2006 to 2018 HHS Decision to Withhold Ban

This is a timeline of actions taken by federal agencies concerning kratom up to the August 16, 2018 HHS decision to withdraw a recommendation to ban kratom. FDA has been the most active federal agency in trying to control kratom, from releasing several import alerts, to requesting shipment seizures, to sending cease and desist letters …

Federal Actions on Kratom: 2006 to 2018 HHS Decision to Withhold Ban Read More »

American Kratom Assn: FDA sat on a letter from HHS reversing kratom ban recommendation in 2018

Previously unreleased HHS letter discovered according to AKA Press Release Via the American Kratom Association (AKA) press conference held today, the Department of Health and Human Services had withdrawn its recommendation back in 2018 to the Drug Enforcement Administration that kratom become a Schedule 1 Drug. The HHS initially recommended kratom be put on Schedule …

American Kratom Assn: FDA sat on a letter from HHS reversing kratom ban recommendation in 2018 Read More »

Interview with Marc Swogger, University of Rochester social scientist

An audio version of this interview can be found here. Dr. Marc Swogger is an associate professor at the University of Rochester Medical Center, Department of Psychiatry. Dr. Swogger is a social scientist and psychologist who studies substance use. He has co-authored multiple studies on the individual and public health effects of the use of …

Interview with Marc Swogger, University of Rochester social scientist Read More »

15. Wade Harman

Kratom Science
15. Wade Harman
/

My guest is Wade Harman from Richlands, Virginia. Wade is a former coal miner, now a freelance writer, kratom consumer of 18 years, and host of the podcast The Botanical Resistance. We talk about FDA links to big pharma, marketing in a kratom-restrictive social media world, and how Wade survived an opiate addiction with the …

15. Wade Harman Read More »

Leading Kratom Scientists Call on FDA, DEA to Keep Kratom Legal

In a recent article published in International Journal of Drug Policy, leading kratom researchers called on the FDA, DEA, and legislators to keep kratom legal, as placing kratom on Schedule 1 would impede research and cause damaging public health consequences. Authors included Chris McCurdy, Andrew Kruegal, Jack Henningfield, and the late Bonnie Avery (who passed …

Leading Kratom Scientists Call on FDA, DEA to Keep Kratom Legal Read More »

Scientists’ Letter to HHS, DEA, FDA, NIDA questions FDA’s handling of Kratom

An open letter to HHS, DEA, NIDA, and FDA signed by twelve leading scientists from various fields has been posted on the website of American Kratom Association. The 33 page letter analyzes and sharply criticizes, piece by piece, the FDA’s 8-Factor Analysis that led the organization to determine that kratom should be placed on the …

Scientists’ Letter to HHS, DEA, FDA, NIDA questions FDA’s handling of Kratom Read More »

Will the FDA Urge the DEA to Make Romaine a Schedule 1 Lettuce?

Kratom supplies are being choked off to American consumers by the actions of both the Indonesian government and the FDA under Trump-appointed Commissioner Scott Gottlieb, M.D. Post mid-term election speculation is appearing all over the internet as to whether the DEA will classify kratom as a Schedule 1 substance, or the FDA will continue to …

Will the FDA Urge the DEA to Make Romaine a Schedule 1 Lettuce? Read More »